Association of some immunological indicators in patients with prostate cancer and UTI
DOI:
https://doi.org/10.48047/z123pr32Keywords:
.Abstract
ABSTRUCT
Prostate cancer is the most common cancer among men in many countries. Urinary tract
infections and chronic inflammation can accelerate prostate carcinogenesis. These disorders are
caused by important microorganisms that are linked to carcinogenesis. This leads to the
stimulation of inflammatory cytokines resulting from exposure to microbial agents. According
to the study's findings, all of the markers—CXCL12, TLR-4, IL-6, and IL-8—were significantly
higher in prostate patients than in controls, with the greatest levels seen in individuals who had
urinary tract infections and prostate disorders. Given their critical involvement in inflammation
and immune cell recruitment during infection, they direct attention to the possible application of
these proteins in the detection of infection in prostate disorders.
Downloads
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
